Nektar Therapeutics | NKTR - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 2.01B 423M 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Alterity Therapeutics Limited AUD 47M 9M 2026-07
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Cipla INR 988.89B 231.9B 2026-03
Dr.Reddys Laboratories INR 1.04T 13.7B 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 10.89B 857M 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.12B 989M 2026-07
MacroGenics USD 287M 103M 2026-07
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
Takeda JPY 9.01T 1.37T 2026-03
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Xencor USD 893M 200M 2026-03